19592582|t|Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
19592582|a|Mutations leading to abrogation of matriptase-2 proteolytic activity in humans are associated with an iron-refractory iron deficiency anemia (IRIDA) due to elevated hepcidin levels. Here we describe two novel heterozygous mutations within the matriptase-2 (TMPRSS6) gene of monozygotic twin girls exhibiting an IRIDA phenotype. The first is the frameshift mutation (P686fs) caused by the insertion of the four nucleotides CCCC in exon 16 (2172_2173insCCCC) that is predicted to terminate translation before the catalytic serine. The second mutation is the di-nucleotide substitution c.467C>A and c.468C>T in exon 3 that causes the missense mutation A118D in the SEA domain of the extracellular stem region of matriptase-2. Functional analysis of both variant matriptase-2 proteases has revealed that they lead to ineffective suppression of hepcidin transcription. We also demonstrate that the A118D SEA domain mutation causes an intra-molecular structural imbalance that impairs matriptase-2 activation. Collectively, these results extend the pattern of TMPRSS6 mutations associated with IRIDA and functionally demonstrate that mutations affecting protease regions other than the catalytic domain may have a profound impact in the regulatory role of matriptase-2 during iron deficiency.
19592582	0	12	Matriptase-2	GeneOrGeneProduct	164656
19592582	26	30	iron	ChemicalEntity	D007501
19592582	42	64	iron deficiency anemia	DiseaseOrPhenotypicFeature	D018798
19592582	65	73	patients	OrganismTaxon	9606
19592582	167	179	matriptase-2	GeneOrGeneProduct	164656
19592582	204	210	humans	OrganismTaxon	9606
19592582	234	272	iron-refractory iron deficiency anemia	DiseaseOrPhenotypicFeature	C562385
19592582	274	279	IRIDA	DiseaseOrPhenotypicFeature	C562385
19592582	297	305	hepcidin	GeneOrGeneProduct	57817
19592582	375	387	matriptase-2	GeneOrGeneProduct	164656
19592582	389	396	TMPRSS6	GeneOrGeneProduct	164656
19592582	443	448	IRIDA	DiseaseOrPhenotypicFeature	C562385
19592582	498	504	P686fs	SequenceVariant	p|FS|P|686||
19592582	520	558	insertion of the four nucleotides CCCC	SequenceVariant	c|INS||CCCC
19592582	571	587	2172_2173insCCCC	SequenceVariant	c|INS|2172_2173|CCCC
19592582	715	723	c.467C>A	SequenceVariant	c|SUB|C|467|A
19592582	728	736	c.468C>T	SequenceVariant	c|SUB|C|468|T
19592582	781	786	A118D	SequenceVariant	p|SUB|A|118|D
19592582	841	853	matriptase-2	GeneOrGeneProduct	164656
19592582	891	903	matriptase-2	GeneOrGeneProduct	164656
19592582	972	980	hepcidin	GeneOrGeneProduct	57817
19592582	1025	1030	A118D	SequenceVariant	p|SUB|A|118|D
19592582	1111	1123	matriptase-2	GeneOrGeneProduct	164656
19592582	1186	1193	TMPRSS6	GeneOrGeneProduct	164656
19592582	1220	1225	IRIDA	DiseaseOrPhenotypicFeature	C562385
19592582	1382	1394	matriptase-2	GeneOrGeneProduct	164656
19592582	1402	1417	iron deficiency	DiseaseOrPhenotypicFeature	D018798
19592582	Association	57817	C562385	No
19592582	Positive_Correlation	C562385	p|SUB|A|118|D	Novel
19592582	Positive_Correlation	C562385	c|SUB|C|468|T	Novel
19592582	Positive_Correlation	C562385	c|SUB|C|467|A	Novel
19592582	Positive_Correlation	C562385	c|INS|2172_2173|CCCC	Novel
19592582	Positive_Correlation	C562385	c|INS||CCCC	Novel
19592582	Positive_Correlation	C562385	p|FS|P|686||	Novel
19592582	Association	D007501	D018798	No
19592582	Negative_Correlation	164656	57817	Novel
19592582	Association	164656	C562385	No
19592582	Association	164656	D018798	No